Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the offered shares involves substantial risks and uncertainties....